ImageneBio, Inc. Other Current Assets
ImageneBio, Inc. (IMA) had Other Current Assets of $1.15 million as of 2023-12-31, per its 10-K filed 2024-03-12.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2024-03-12
- 2023-12-31: Other Assets, Current $1.15M.
- 2023-09-30: Other Assets, Current $1.02M.
- 2023-06-30: Other Assets, Current $731.00K.
- 2023-03-31: Other Assets, Current $1.41M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2023-12-31 | $1.15M 10-K · filed 2024-03-12 | |
| 2023-09-30 | $1.02M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $731.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.41M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $964.00K 10-K · filed 2024-03-12 | |
| 2022-09-30 | $1.18M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $2.30M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.05M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $629.00K 10-K · filed 2023-03-14 | |
| 2021-09-30 | $1.03M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $491.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $634.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.54M 10-K · filed 2022-03-17 | $1.56M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |